Perioperative Dexmedetomidine Exposure and Postoperative Cardiac Biomarkers after Cardiopulmonary Bypass: A Retrospective Cohort Study
Pakistan Heart Journal · 28.02.2026 · 59 (1) · 184-193
DOI: 10.47144/phj.v59i1.3459 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pakistan Heart Journal, online erschienen am 28.02.2026. Verfasst von Jawad Hameed und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the association between perioperative dexmedetomidine exposure and postoperative myocardial injury biomarkers in adults undergoing cardiopulmonary bypass (CPB)–assisted cardiac surgery. Methodology: This retrospective cohort study was conducted at Lady Reading Hospital, Peshawar, Pakistan, from 1 January 2023 to 31 December 2024. Adult patients undergoing CPB-assisted cardiac surgery with at least one postoperative high-sensitivity cardiac troponin T (hs-cTnT) measurement within 72 hours were included. Dexmedetomidine exposure was categorized by initiation timing. The primary outcome was peak hs-cTnT within 72 hours. Secondary outcomes included hs-cTnT at ICU admission, peak creatine kinase–MB (CK-MB), ventilation duration, ICU length of stay, documented delirium, bradycardia requiring intervention, and in-hospital mortality. Log-linear regression models were used, adjusting for CPB time and aortic cross-clamp time. Timing-restricted sensitivity analyses excluded ICU-only initiation for time-dependent outcomes.
Results
Of 261 screened patients, 232 were included (dexmedetomidine n=122; control n=110). Peak hs-cTnT was lower in dexmedetomidine-exposed patients (median 1120 vs 1360 ng/L; p=0.004), with an adjusted geometric mean ratio of 0.84 (95% CI 0.73–0.96; p=0.012). Peak CK-MB was also lower (p=0.03). Dexmedetomidine exposure was associated with shorter ventilation duration, shorter ICU stay, lower documented delirium, and higher bradycardia requiring intervention. In timing-restricted analyses, the ventilation-duration association persisted, while ICU length of stay attenuated. In-hospital mortality did not differ.
Conclusion
Perioperative dexmedetomidine exposure was associated with lower postoperative cardiac biomarker release, with cautious interpretation warranted for time-dependent outcomes.
Zitieren
APA
Hameed, J., Batool, H. T., Akhtar, A., Imran, M., Khattak, A. H., & Ashraf, M. S. (2026). Perioperative Dexmedetomidine Exposure and Postoperative Cardiac Biomarkers after Cardiopulmonary Bypass: A Retrospective Cohort Study. Pakistan Heart Journal, 59(1), 184-193. https://doi.org/10.47144/phj.v59i1.3459
Vancouver
Hameed J, Batool HT, Akhtar A, Imran M, Khattak AH, Ashraf MS. Perioperative Dexmedetomidine Exposure and Postoperative Cardiac Biomarkers after Cardiopulmonary Bypass: A Retrospective Cohort Study. Pakistan Heart Journal. 2026;59(1):184-193. doi:10.47144/phj.v59i1.3459
BibTeX
@article{Hameed2026,
author = {Hameed, Jawad and Batool, Hadiqa Tul and Akhtar, Asad and Imran, Muhammad and Khattak, Abid Haleem and Ashraf, Muhammad Sheharyar},
title = {Perioperative Dexmedetomidine Exposure and Postoperative Cardiac Biomarkers after Cardiopulmonary Bypass: A Retrospective Cohort Study},
journal = {Pakistan Heart Journal},
year = {2026},
volume = {59},
number = {1},
pages = {184--193},
doi = {10.47144/phj.v59i1.3459}
}
EUVIMED